[ad_1]
360 MARKETS UPDATE The report provides a 360-degree overview of the global colorectal cancer screening market with a focus on all aspects, including determinants, constraints, opportunities, market segmentation and region.
"Global Colorectal Cancer Screening Market – Segmented by Test Type – Growth, Trends and Forecasts (2018 – 2023)" The market report provides the landscape of competition in the global marketplace, market drivers and trends, opportunities and challenges, risks and barriers to entry, sales channels, distributors and distributors. 39, screening for colorectal cancer. The colorectal cancer screening market is expected to register a CAGR's about 4.38% during the forecast period (2019-2024).
Market Report for Colorectal Cancer Screening Main manufacturers: ALERE INC, CLINICAL GENOMICS, BECKMAN COULTER, ABBOTT LABORATORIES, EXACT SCIENCES CORP, HEMOSURE, EIKEN CHEMICAL, QUIDEL COMPANY, NOVIGENIX SA, SYSMEX CORPORATION, EPIGENOMICS AG
Get an example of a PDF report – https://www.360marketupdates.com/enquiry/request-sample/12883600
The global market for colorectal cancer screening has been estimated at USD 727.08 million for 2017. The market is expected to record a CAGR's 4.38% during the forecast period, 2018 to 2023. The Asia-Pacific region is expected to experience substantial growth over the forecast period.
The advent of effective genetic testing
Genetic testing for colon cancer offers better opportunities for early diagnosis. It is highly recommended by the medical community. Screening for mutations responsible for colon cancer is only beginning to be done outside research laboratories. If these medical screenings are set up, the number of cases of colon cancer detected in the early stages would increase. In addition, gene therapies to modify these mutations will probably be developed. The growing awareness of genetic testing methods and the benefits of testing – not for early detection and treatment, but also for the elimination of precancerous cells, much less expensive than usual chemotherapy – is the driving force of the market .
In addition, the increase in the prevalence population, the potential product portfolio and the growing cancer prevention initiatives are also fueling the global colorectal cancer screening market.
High cost of screening tests
Many high-income countries, including the United Kingdom and the United States, face the challenge of providing care to an increasing population of cancer patients because of the high cost of treatment. Although screening tests for CRC have early detection potential, they are rarely used. The high cost of these tests hampers market growth. Expenses badociated with a colorectal cancer diagnosis are increasing rapidly, even if you are insured. Although many private insurance plans cover the costs of colonoscopy as a screening test, some patients may still be charged for certain services, which again becomes a burden. All costs of testing are not covered by insurance companies; For example: Medicare does not cover the cost of virtual colonoscopy (colonography by scanner, which costs more than colonoscopy).
In addition, insufficient access to health care in developing countries and the lack of screening guidelines in Asia-Pacific restrict the global market for colorectal cancer screening.
North America dominates the market
The global market for colorectal cancer screening tests is segmented into test types, which are also segmented into fecal occult blood test in Guaiac stool, fecal immunochemical, stool DNA and others. Geographically, it is segmented into North America, Europe, Asia-Pacific, Middle East, Africa and South America.
North America dominates the colorectal cancer screening market due to the high incidence of colorectal cancer and the increase in the geriatric population in the North American region. Colon cancer is reported to be the second most deadly cancer in the United States with 50,000 deaths a year, followed by lung cancer. The increasing incidence of colorectal cancer is driving the market in the United States; approximately 1 44 000 cases of colorectal cancer were discovered in 2015 in the country and 1 60 000 new cases of colorectal cancer are expected to occur by 2020. This increase in the disease will eventually increase the demand for colorectal cancer screening procedures. colorectal cancer.
Order a copy of the colorectal cancer screening market report – https://www.360marketupdates.com/purchase/12883600
Reasons to buy the market report for colorectal cancer screening:
- Identification of key factors that have contributed to changing the market scenario, exploiting new opportunities and gaining a competitive advantage.
- Analyze different market perspectives using Porter's Five Forces badysis.
- The authentication mode will probably be the witness of the strongest adoption of these systems on the market.
- Regions expected to grow fastest during the forecast period.
- SWOT badysis for key players and a detailed study of their current strategic interests and key financial performance indicators.
- 3 months of help to badysts as well as the market estimation sheet (in Excel format).
"We can also offer a customized report to meet the specific requirements of our customers. A report on regions and countries can also be provided. "
Tagged: – Google News, Colorectal Cancer Screening Market, European Colorectal Cancer Screening Market, APAC Colorectal Cancer Screening Market, Colorectal Cancer Screening Market by Application, Colorectal Cancer Screening Market by Increasing Trend, Market Development Colorectal Cancer Screening, Colorectal Cancer Screening Market Forecasts, Colorectal Cancer Screening Market Futures, Colorectal Cancer Screening Market Growth, Colorectal Cancer Screening Market in Key Countries, Next Generation Market Report Colorectal Cancer Screening, Colorectal Cancer Swot Analysis
Source link
